http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004067197-A1

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-351
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0491
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113
filingDate 2001-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe863ef0549121c1ed538b3fbed41984
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ad172ad4301d85f26b0208bf142a402
publicationDate 2004-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2004067197-A1
titleOfInvention Radiolabeled DNA carrier, method of preparation and therapeutic uses thereof
abstract The present invention relates to a radiolabeled DNA carrier, a method of preparation thereof and the therapeutic uses of this substance to prevent uncontrolled cellular proliferation. The invention also relates to devices incorporating the above radiolabeled DNA carrier (such as an oligonucleotide) for the therapeutic treatment of uncontrolled cellular proliferation. More specifically, the present invention is concerned with the prevention of restenosis by intravascular delivery of radiolabeled DNA carrier at a dilatation site of an artery. This invention is also directed to a method of treatment of vascular proliferative diseases and/or other proliferative disorders such as cancer and related metastasis. More particularly, the invention relates to the preparation of DNA sequences carrying one or several radioisotopes, located within the DNA sequence, and which are able to prevent cell proliferation in vitro and, pursuant to local drug delivery and/or systemic drug delivery, are able to prevent cell proliferation in vivo, more particularly restenosis and malignant tumors. In other words, the invention relates to the synthesis process, the stability data of the radiolabeled DNA carrier, the efficacy of the invention in vitro, in cell culture, and the in vivo delivery of the molecule.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7744584-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8303934-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10441747-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012039908-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11083877-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8642007-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10849879-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9011879-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9199065-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008240496-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10617678-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011104060-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8708995-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9061098-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011104061-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012128582-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8465752-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8399443-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10576063-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004138643-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10925863-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11654267-B2
priorityDate 1997-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439357
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409525
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393971
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402238
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445639
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3037556
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57479296
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409332
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129445658
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408335
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5917
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280450
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408336
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421056
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406750
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135732338
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398492
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226483760
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57199466
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7244
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128922443
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3763
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5789
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397717
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56976340
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13818
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8272
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID637517
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129765906
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID985
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4763
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127688846
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1134
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409524
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393970

Total number of triples: 74.